Observational study reveals reduced accuracy of liver stiffness for portal hypertension in obese patients with NASH, suggesting tailored diagnostic cutoffs are needed.
Patients with cACLD of NASH etiology, especially obese patients with NASH, present lower prevalences of portal hypertension compared with other cACLD etiologies. LSM ≥25 kPa is sufficient to rule in CSPH in most etiologies, including nonobese patients with NASH, but not in obese patients with NASH.
No takes yet. Share an insight, caveat, or question.
Pons et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: